Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis

References

• Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010;153(2):109–20.
   PubMed Web of Science ®Google Scholar
• Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14(5):548–52.
   PubMed Web of Science ®Google Scholar
• Yasuda S, Tsutsumi A, Nakabayashi T, Horita T, Ichikawa K, Ieko M, Koike T. Haemophagocytic syndrome in a patient with dermatomyositis. Br J Rheumatol. 1998;37(12):1357–8.
   PubMedGoogle Scholar
• Kobayashi I, Yamada M, Kawamura N, Kobayashi R, Okano M, Kobayashi K. Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr. 2000;89(5):617–9.
   PubMed Web of Science ®Google Scholar
• Madaule S, Porte L, Couret B, Arlet-Suau E. Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies. Rheumatology (Oxford). 2000;39(10):1157–8.
   PubMed Web of Science ®Google Scholar
• Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47(11):1686–91.
   PubMed Web of Science ®Google Scholar
• Yajima N, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, Miwa Y, et al. Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol. 2008;35(9):1838–41.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Matsuki Y, Shimizu A, Mochizuki M, Takahashi Y, Kano T, Mimori A. Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Mod Rheumatol. 2013;23:386–92.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.
   PubMed Web of Science ®Google Scholar
• Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65(12):1596–601.
   PubMed Web of Science ®Google Scholar
• Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, Ezaki H. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2005;23(1):100–2.
   PubMed Web of Science ®Google Scholar
• Pinto L, Kagalwala F, Singh S, Balakrishnan C, Prabhu SV, Khodaiji S. Macrophage activation syndrome: experience from a tertiary referral centre. J Assoc Physicians India. 2007;55:185–7.
   PubMedGoogle Scholar
• Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, Tsunematsu Y. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995;86(12):4706–7.
   PubMed Web of Science ®Google Scholar
• Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood. 1989;73:2128–32.
   PubMed Web of Science ®Google Scholar
• Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis and rheumatism. 2007;56(3):965–71.
   PubMed Web of Science ®Google Scholar
• Coca A, Bundy KW, Marston B, Huggins J, Looney RJ. Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin Immunol. 2009;132(1):10–8.
   PubMed Web of Science ®Google Scholar
• Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78(11):2918–22.
   PubMed Web of Science ®Google Scholar
• Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100–3.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Yokoyama T, Tokuhisa Y, Ishikawa S, Sakakibara Y, Ueno K, et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol. 2013;146(2):73–6.
   PubMed Web of Science ®Google Scholar
• Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages. Blood. 2005;105(4):1648–51.
   PubMed Web of Science ®Google Scholar
• Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K. Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness. Intern Med. 2001;40(10):1037–40.
   PubMed Web of Science ®Google Scholar
• Nakakura H, Ashida A, Matsumura H, Murata T, Nagatoya K, Shibahara N, et al. A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl. Ther Apher Dial. 2009;13(1):71–6.
   PubMed Web of Science ®Google Scholar
• McCann LJ, Hasson N, Pilkington CA. Macrophage activation syndrome as an early presentation of Lupus. J Rheumatol. 2006;33(2):438–40.
   PubMed Web of Science ®Google Scholar
• Benson A, Barrett T, Sparberg M, Buchman AL. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience. Inflamm Bowel Dis. 2008;14(1):7–12.
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Kawai S, Hashimoto H. Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study. Mod Rheumatol. 2009;19(6):606–15.
   PubMed Web of Science ®Google Scholar
• Kaieda S, Kobayashi T, Moroki M, Honda S, Yuge K, Kawano H, et al. Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus. Mod Rheumatol. 2012; in press.
   PubMed Web of Science ®Google Scholar
• Kitahara K, Kawai S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2007;19(3):238–45.
   PubMed Web of Science ®Google Scholar
• Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford). 2001;40(11):1285–92.
   PubMed Web of Science ®Google Scholar
• Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129(5): 750–4.
   PubMed Web of Science ®Google Scholar
• Miyabe Y, Murata Y, Baba Y, Ito E, Nagasaka K. Successful treatment of cyclosporine-A-resistant cytophagic histiocytic panniculitis with tacrolimus. Mod Rheumatol. 2011;21(5):553–6.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Hirase N, Goda H, Nishikawa H, Ikuyama S. Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus. Mod Rheumatol. 2012; 22(2):284–9.
   PubMed Web of Science ®Google Scholar